[III. Molecular targeting therapy for glioma-bevacizumab and cilengitide]

Gan To Kagaku Ryoho. 2013 Jun;40(6):718-22.
[Article in Japanese]
No abstract available

MeSH terms

  • Angiogenesis Inducing Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Clinical Trials as Topic
  • Glioma / drug therapy*
  • Humans
  • Molecular Targeted Therapy*
  • Snake Venoms / therapeutic use*

Substances

  • Angiogenesis Inducing Agents
  • Antibodies, Monoclonal, Humanized
  • Snake Venoms
  • Bevacizumab
  • Cilengitide